54445-64-6

Basic information

• Product Name: Cyclobutane-1β,2β-dimethanol
• Synonyms: (1R,2S)-1,2-Cyclobutanedimethanol;(1S)-Cyclobutane-1α,2α-bismethanol;(1S)-Cyclobutane-1α,2α-dimethanol;cis-1,2-Cyclobutanedimethanol;Cyclobutane-1α,2α-dimethanol;Cyclobutane-1β,2β-dimethanol;[1S,2S,(+)]-1,2-Cyclobutanedimethanol;cis-cyclobutane-1,2-diyldimethanol
• CAS NO: 54445-64-6
• Molecular Formula: C₆H₁₂O₂
• Molecular Weight: 116.15828
• Mol File: 54445-64-6.mol
• Article Data: 15

Chemical Properties

• Appearance: /
• CAS DataBase Reference: Cyclobutane-1β,2β-dimethanol(CAS DataBase Reference)
• NIST Chemistry Reference: Cyclobutane-1β,2β-dimethanol(54445-64-6)
• EPA Substance Registry System: Cyclobutane-1β,2β-dimethanol(54445-64-6)

Safety Data

• Hazardous Substances Data: 54445-64-6(Hazardous Substances Data)

Upstream product

• 10268-82-3 diethyl trans-1,2-cyclobutanedicarboxylate 
• 2607-03-6 dimethyl cis-1,2-cyclobutanedicarboxylate 
• 3396-14-3 (RR,SS)-trans-1,2-cyclobutanedicarboxylic acid 
• 412346-70-4 1-cyano-cyclobutane-1,2-dicarboxylic acid diethyl ester 
• 869-10-3 diethyl 2,5-dibromoadipate 
• 10268-82-3 diethyl cis-1,2-cyclobutanedicarboxylate 
• 7371-67-7 dimethyl trans-1,2-cyclobutane dicarboxylate 
• 1124-13-6 (+/-)-(1S,2S)-cyclobutane-1,2-dicarboxylic acid 
• 3396-17-6 trans-1,2-dicyanocyclobutane 
• 4462-96-8 3-oxabicyclo[3.2.0]heptane-2,4-dione 
• 4462-96-8 cis-1,2-cyclobutane dicarboxylic anhydride 

Downstream Products

• 2235-12-3 1,3,5-hexatriene 
• 1165952-91-9 cyclohexa-1,3-diene 
• 371784-53-1 ((1R,2R)-2-formylcyclobutyl)methyl acetate 
• 1883727-34-1 (1S,3'R,6'R,7'S,8'Z,11'S,12'R)-6-chloro-7'-methoxy-11',12'-dimethyl-3,4-dihydro-2H,15'H-spiro[naphthalene-1,22'-[20]oxa[13]thia[1,14]diazatetracyclo[14.7.2.0³'⁶.0¹⁹'²⁴]pentacosa[8,16,18,24]tetraen]-15'-one 13',13'-dioxide 
• 1883727-34-1 (1S,3’R,6’R,7’S,9’E,11’S,12’R)-6-chloro-7'-methoxy-11’,12’-dimethyl-3,4-dihydro-2H,15’H-spiro[naphthalene-1,22’-[20]oxa[13]thia[1,14]diazatetracyclo[14.7.2.03,6.019,24]pentacosa[9,16,18,24]tetraen]-15’-one-13’,13'-dioxide 
• 134877-12-6 (+)-(1S,2R)-1-carbomethoxy-2-methylcyclobutane 
• 55659-54-6 (-)-(1R,2R)-1,2-bis(hydroxymethyl)cyclobutane 
• 206991-69-7 cis-1,2-bis((mesitylenesulfonyloxy)methyl)cyclobutane 
• 77774-09-5 cis-Cyclobutane-1,2-diylbis<(methyleneoxy)triphenylphosphonium triflate> 
• 791-28-6 Triphenylphosphine oxide 

Relevant articles and documents

Understanding the Structure–Polymerization Thermodynamics Relationships of Fused-Ring Cyclooctenes for Developing Chemically Recyclable Polymers

Polymers that can be chemically recycled to their constituent monomers offer a promising solution to address the challenges in plastics sustainability through a circular use of materials. The design and development of monomers for next-generation chemical

Hydrogenated Poly(Dewar benzene): A Compact Cyclic Olefin Polymer with Enhanced Thermomechanical Properties

Dihydro Dewar benzene(bicyclo[2.2.0]hex-2-ene) was synthesized and polymerized using the Grubbs third generation catalyst. The corresponding ring-opening metathesis polymerization proceeded in a controlled manner, as determined by a linear relationship between the molecular weight of the polymer produced and the monomer-To-catalyst feed ratio as well as an ability to extend polymer chains through exposure to an additional monomer. Subsequent treatment with tosylhydrazide afforded the corresponding hydrogenated derivative. The hydrogenated polymer was found to exhibit high melting and decomposition temperatures as well as a relatively high Young's modulus when compared to other polyolefins [e.g., hydrogenated poly(norbornene) and poly(ethylene)]. The enhanced thermal and mechanical properties were found to originate from a relatively low phase transition entropy combined with high polymer crystallinity, features that were attributed to restricted bond rotation within the repeating units of the hydrogenated polymer.

MACROCYCLIC CHLORINE SUBSTITUTED INDOLE DERIVATIVES

The present invention relates to macrocyclic indole derivatives of general formula (I) : in which R1, R2, R3, R4, R5, R6, A and L are as defined herein, methods of preparing said compounds, intermediate compounds useful for preparing said compounds, pharmaceutical compositions and combinations comprising said compounds, and the use of said compounds for manufacturing pharmaceutical compositions for the treatment or prophylaxis of diseases, in particular of hyperproliferative disorders, as a sole agent or in combination with other active ingredients.